[ad_1]
For beauty nerds, the announcement of a new neuromodulator is always cause for excitement. Such was the case in September 2022, when the FDA finally approved Revance’s Daxxify, a botulinum toxin (daxibotulinumtoxinA-lanm) specifically for use on the glabellar lines, aka the “11s” that can appear …
[ad_2]
Hannah Baxter
Source link